Arthrex Launches First FDA-Cleared ACL Primary Repair Kit
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Arthrex, a global leader in minimally invasive orthopedic technology, announced today the launch of the SwiveLock® ACL Repair Kit, following clearance by the U.S. Food and Drug Administration of the SwiveLock® anchor for ACL repair. It is the first and only FDA-cleared kit for the primary repair of anterior cruciate ligament (ACL) tears.

Arthrex is defining the future for ACL treatment as the first orthopedic company to develop and market a kit specifically for ACL repair.

ACL primary repair with the SwiveLock® ACL Repair Kit involves reattaching a torn ACL utilizing SwiveLock® anchors and high-strength FiberWire® and TigerWire® sutures. The repair utilizes an InternalBrace™ ligament augmentation, which enables patients to return to activity more quickly while protecting the repaired ligament. The kit is convenient and contains all the surgical products needed for the ACL repair technique.

Traditional treatment for most ACL tears involves a surgical reconstruction technique, in which graft tissue from the patient's body or donor tissue is used to recreate the damaged ligament. The kit is indicated for use in proximal ACL tears (tears off the femur), which results in roughly 16% of all ACL tears.

ACL primary repair offers a fully arthroscopic, more minimally invasive and patient-friendly surgical option for certain types of tears when compared to traditional reconstruction techniques. Arthrex innovations in technology and techniques provides surgeons the potential to restore a patient's native anatomy and proprioception. These advancements may allow for a quicker return to activity and diminish pain following the procedure. While primary 'repair' will not replace reconstruction for all cases, the procedure, utilizing the SwiveLock® ACL Repair Kit, is valuable tool to help surgeons treat their patients better.

Arthrex has been involved in developing the ACL primary repair procedure since 1983 with the goal of helping patients maintain their native tissue while returning to activity more quickly.